Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 31-40 of 110
Item hits:
Issue DateTitleAuthor(s)
21-Apr-2016Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPFMercer, PF; Woodcock, HV; Eley, JD; Plate, M; Sulikowski, MG, et al
31-Mar-2016Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysisKreuter, M; Wuyts, W; Renzoni, E; Koschel, D; Maher, TM, et al
8-Mar-2016Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosisEvans, IC; Barnes, JL; Garner, IM; Pearce, DR; Maher, TM, et al
1-Mar-2019A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosisLukey, PT; Harrison, SA; Yang, S; Man, Y; Holman, BF, et al
2-Jan-2019The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisWoodcock, HV; Eley, JD; Guillotin, D; Platé, M; Nanthakumar, CB, et al
1-Feb-2019Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A multidisciplinary approach to address challenges and opportunitiesFischer, A; Strek, ME; Cottin, V; Dellaripa, PF; Bernstein, EJ, et al
1-Dec-2017Towards a global initiative for fibrosis treatment (GIFT).Molina-Molina, M; Agusti, A; Crestani, B; Schwartz, DA; Königshoff, M, et al
1-Oct-2018Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialVisca, D; Mori, L; Tsipouri, V; Fleming, S; Firouzi, A, et al
3-Jan-2019Predicting outcomes in rheumatoid arthritis related interstitial lung diseaseJacob, J; Hirani, N; Van Moorsel, CHM; Rajagopalan, S; Murchison, JT, et al
10-Jan-2019No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidoneRicheldi, L; Fletcher, S; Adamali, H; Chaudhuri, N; Wiebe, S, et al